Calendar
event
Ex dividend date
16 Apr 2026
event_available
Last Dividend Payment
01 Jan 1970
About ConvaTec Group PLC
Ticker
info
CTEC
Trading on
info
LSE
ISIN
info
GB00BD3VFW73
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Jonathan Peter Mason
Headquarters
info
20 Eastbourne Terrace, London, undefined, United Kingdom, W2 6LG
Employees
info
10,910
Website
info
convatecgroup.com
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Metrics
BasicAdvanced
Market cap
info
£4.6B
P/E ratio
info
39.33
EPS
info
GBX 0.06
Dividend Yield
info
3.05%
Beta
info
0.76
Forward P/E ratio
info
15.92
EBIDTA
info
£587M
Ex dividend date
info
2026-04-16
Price & volume
Market cap
info
£4.6B
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
GBX 0.07
Dividend yield
info
3.05%
Forward dividend per share
info
GBX 0.05
Forward dividend yield
info
2.28%
Payout ratio
info
62.98%
Valuation
P/E ratio
info
39.33
Forward P/E
info
15.92
PEG ratio
info
1.59
Trailing P/E
info
39.33
Price to sales
info
1.89
Price to book
info
4.06
Earnings
EPS
info
GBX 0.06
EPS estimate (current quarter)
info
GBX 0.00
EPS estimate (next quarter)
info
GBX 0.00
EBITDA
info
£587M
Revenues (TTM)
info
£2.44B
Revenues per share (TTM)
info
GBX 1.21
Technicals
Beta
info
0.76
52-week High
info
GBX 309.42
52-week Low
info
GBX 209.40
50-day moving average
info
GBX 235.83
200-day moving average
info
GBX 242.78
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
10.91%
ROA (TTM)
info
7.02%
Profit margin
info
7.18%
Gross profit margin
info
£1.37B
Operating margin
info
18.08%
Growth
Quarterly earnings growth (YoY)
info
-36.50%
Quarterly revenue growth (YoY)
info
7.10%
Share stats
Outstanding Shares
info
1.95B
Float
info
1.94B
Insiders %
info
0.17%
Institutions %
info
78.66%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
GBX 0.08
GBX 0.09
-1.86%
Q4 • 24Missed
-
-
-
Q1 • 25Beat
GBX 0.08
GBX 0.08
-
Q2 • 25Beat
-
GBX 0.10
-
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
£1.18B
£105M
8.88%
Q2 • 25
£1.27B
£70.5M
5.58%
Q4 • 25
7.22%
-32.69%
-37.23%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
£3.77B
£1.96B
51.98%
Q2 • 25
£3.78B
£2.26B
59.85%
Q4 • 25
0.29%
15.48%
15.15%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
£155M
-
£-32.1M
£98.4M
Q2 • 25
£311M
-
£-226M
£247M
Q4 • 25
100.65%
-
603.83%
150.86%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a ConvaTec Group PLC share?
Collapse

ConvaTec Group PLC shares are currently traded for undefined per share.

How many shares does ConvaTec Group PLC have?
Collapse

ConvaTec Group PLC currently has 1.95B shares.

Does ConvaTec Group PLC pay dividends?
Collapse

Yes, ConvaTec Group PLC does pay dividends.

What is ConvaTec Group PLC 52 week high?
Collapse

ConvaTec Group PLC 52 week high is GBX 309.42.

What is ConvaTec Group PLC 52 week low?
Collapse

ConvaTec Group PLC 52 week low is GBX 209.40.

What is the 200-day moving average of ConvaTec Group PLC?
Collapse

ConvaTec Group PLC 200-day moving average is GBX 242.78.

Who is ConvaTec Group PLC CEO?
Collapse

The CEO of ConvaTec Group PLC is Jonathan Peter Mason.

How many employees ConvaTec Group PLC has?
Collapse

ConvaTec Group PLC has 10,910 employees.

What is the market cap of ConvaTec Group PLC?
Collapse

The market cap of ConvaTec Group PLC is £4.6B.

What is the P/E of ConvaTec Group PLC?
Collapse

The current P/E of ConvaTec Group PLC is 39.33.

What is the EPS of ConvaTec Group PLC?
Collapse

The EPS of ConvaTec Group PLC is GBX 0.06.

What is the PEG Ratio of ConvaTec Group PLC?
Collapse

The PEG Ratio of ConvaTec Group PLC is 1.59.